Cardiovascular diseases and complication in COVID-19

From the late fall of 2019 until the beginning of 2020, SARS-CoV-2 infection is becoming the biggest global challenge of health systems worldwide. Characteristic of the encounter with the disease caused by COVID-19 was a certain wandering in the mechanisms of action of the virus, its consequences, a...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autor principal:	Pavlović Siniša
Formato:	article
Lenguaje:	EN SR
Publicado:	University of Belgrade, Medical Faculty 2021
Materias:	sars-cov-2 cardiovascular thromboembolic Medicine R
Acceso en línea:	https://doaj.org/article/574b09014f4843c9a7c4394f5f5f4fc4
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:574b09014f4843c9a7c4394f5f5f4fc4
record_format	dspace
spelling	oai:doaj.org-article:574b09014f4843c9a7c4394f5f5f4fc42021-12-05T21:26:50ZCardiovascular diseases and complication in COVID-190369-15272466-552510.5937/mp72-33011https://doaj.org/article/574b09014f4843c9a7c4394f5f5f4fc42021-01-01T00:00:00Zhttps://scindeks-clanci.ceon.rs/data/pdf/0369-1527/2021/0369-15272103065P.pdfhttps://doaj.org/toc/0369-1527https://doaj.org/toc/2466-5525From the late fall of 2019 until the beginning of 2020, SARS-CoV-2 infection is becoming the biggest global challenge of health systems worldwide. Characteristic of the encounter with the disease caused by COVID-19 was a certain wandering in the mechanisms of action of the virus, its consequences, and thus in therapy. Various manifestations of the disease confirm the assumption that it is a systemic infection with the respiratory system as an entry route. We were also faced with the fact that the SARS-CoV-2 virus has great implications for the cardiovascular system. Patients with cardiovascular risk factors, including male gender, advanced age, diabetes, hypertension, and obesity, as well as patients with established cardiovascular and cerebrovascular disease, have been identified as particularly susceptible populations with increased morbidity and mortality from COVID-19. The effects on the cardiovascular system are reminiscent of other diseases caused by this group of viruses. There are biochemical, electrocardiographic and echocardiographic confirmations of functional disorders. It is basically an immune response caused by tissue inflammation, which results in prothrombogenicity as the dominant and biggest problem, coupled with the highest risk of a possible bad outcome. Being a systemic disease with numerous and different repercussions on the cardiovascular system, COVID-19 can lead to the appearance of all cardiovascular diseases that the patient did not have before, or to a significant worsening of the existing cardiovascular disease. The condition after the disease in most cases also means recovery, but great caution is needed due to possible time-distant complications. Since there is a high risk of death in the end, it is necessary to apply all available measures, especially in the field of prevention of thromboembolic complications, as a factor of the greatest risk of a bad outcome.Pavlović SinišaUniversity of Belgrade, Medical Facultyarticlesars-cov-2cardiovascularthromboembolicMedicineRENSRMedicinski Podmladak, Vol 72, Iss 3, Pp 65-69 (2021)
institution	DOAJ
collection	DOAJ
language	EN SR
topic	sars-cov-2 cardiovascular thromboembolic Medicine R
spellingShingle	sars-cov-2 cardiovascular thromboembolic Medicine R Pavlović Siniša Cardiovascular diseases and complication in COVID-19
description	From the late fall of 2019 until the beginning of 2020, SARS-CoV-2 infection is becoming the biggest global challenge of health systems worldwide. Characteristic of the encounter with the disease caused by COVID-19 was a certain wandering in the mechanisms of action of the virus, its consequences, and thus in therapy. Various manifestations of the disease confirm the assumption that it is a systemic infection with the respiratory system as an entry route. We were also faced with the fact that the SARS-CoV-2 virus has great implications for the cardiovascular system. Patients with cardiovascular risk factors, including male gender, advanced age, diabetes, hypertension, and obesity, as well as patients with established cardiovascular and cerebrovascular disease, have been identified as particularly susceptible populations with increased morbidity and mortality from COVID-19. The effects on the cardiovascular system are reminiscent of other diseases caused by this group of viruses. There are biochemical, electrocardiographic and echocardiographic confirmations of functional disorders. It is basically an immune response caused by tissue inflammation, which results in prothrombogenicity as the dominant and biggest problem, coupled with the highest risk of a possible bad outcome. Being a systemic disease with numerous and different repercussions on the cardiovascular system, COVID-19 can lead to the appearance of all cardiovascular diseases that the patient did not have before, or to a significant worsening of the existing cardiovascular disease. The condition after the disease in most cases also means recovery, but great caution is needed due to possible time-distant complications. Since there is a high risk of death in the end, it is necessary to apply all available measures, especially in the field of prevention of thromboembolic complications, as a factor of the greatest risk of a bad outcome.
format	article
author	Pavlović Siniša
author_facet	Pavlović Siniša
author_sort	Pavlović Siniša
title	Cardiovascular diseases and complication in COVID-19
title_short	Cardiovascular diseases and complication in COVID-19
title_full	Cardiovascular diseases and complication in COVID-19
title_fullStr	Cardiovascular diseases and complication in COVID-19
title_full_unstemmed	Cardiovascular diseases and complication in COVID-19
title_sort	cardiovascular diseases and complication in covid-19
publisher	University of Belgrade, Medical Faculty
publishDate	2021
url	https://doaj.org/article/574b09014f4843c9a7c4394f5f5f4fc4
work_keys_str_mv	AT pavlovicsinisa cardiovasculardiseasesandcomplicationincovid19
_version_	1718371001859833856

Cardiovascular diseases and complication in COVID-19

Ejemplares similares